Marina Deodato

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Stefano Luminari, Michele Merli, Sara Rattotti et al. · Blood · 2019 · 84 citations · Full text

Medicine, Oncology, Pathology +14

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial

Alessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci et al. · The Lancet Oncology · 2024 · 33 citations

Medicine, Hematology, Oncology +14

Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network

Marzia Varettoni, Emanuela Boveri, Silvia Zibellini et al. · American Journal of Hematology · 2019 · 32 citations · Full text

Medicine, Hematology, Pathology +13

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

Livio Pagano, Marianna Criscuolo, Alessandro Broccoli et al. · Blood Cancer Journal · 2022 · 31 citations · Full text

Medicine, Hematology, Pharmacology +11

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

Alessandra Tedeschi, Anna Maria Frustaci, Francesca Romana Mauro et al. · Blood Advances · 2021 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +14